EP2470542A4 - Preparation of sitagliptin and salts thereof - Google Patents
Preparation of sitagliptin and salts thereofInfo
- Publication number
- EP2470542A4 EP2470542A4 EP10812650.9A EP10812650A EP2470542A4 EP 2470542 A4 EP2470542 A4 EP 2470542A4 EP 10812650 A EP10812650 A EP 10812650A EP 2470542 A4 EP2470542 A4 EP 2470542A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- sitagliptin
- salts
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2090CH2009 | 2009-08-28 | ||
US31090010P | 2010-03-05 | 2010-03-05 | |
PCT/US2010/046938 WO2011025932A2 (en) | 2009-08-28 | 2010-08-27 | Preparation of sitagliptin and salts thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2470542A2 EP2470542A2 (en) | 2012-07-04 |
EP2470542A4 true EP2470542A4 (en) | 2013-04-24 |
Family
ID=43628673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10812650.9A Withdrawn EP2470542A4 (en) | 2009-08-28 | 2010-08-27 | Preparation of sitagliptin and salts thereof |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2470542A4 (en) |
WO (1) | WO2011025932A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102838603B (en) * | 2011-06-24 | 2015-05-13 | 上海医药工业研究院 | Preparation method of intermediate compound of sitagliptin |
WO2013001514A1 (en) | 2011-06-29 | 2013-01-03 | Ranbaxy Laboratories Limited | Solid dispersions of sitagliptin and processes for their preparation |
WO2013001457A1 (en) | 2011-06-30 | 2013-01-03 | Ranbaxy Laboratories Limited | Novel salts of sitagliptin |
WO2013065066A1 (en) * | 2011-11-02 | 2013-05-10 | Cadila Healthcare Limited | Processes for preparing 4-oxo-4-[3-(trifluoromethyl)-5,6- dihydro [l,2,41-triazolo[43-a]pyrazin-7(8h)-yl]-l-(2,4,5- trifluorophenyl)butan-2-amine |
EP2788352A1 (en) | 2011-12-08 | 2014-10-15 | Ranbaxy Laboratories Limited | Amorphous form of sitagliptin salts |
EP2674432A1 (en) | 2012-06-14 | 2013-12-18 | LEK Pharmaceuticals d.d. | New synthetic route for the preparation of ß aminobutyryl substituted 5,6,7,8-tetrahydro[1,4]diazolo[4,3-alpha]pyrazin-7-yl compounds |
CN104447753B (en) * | 2013-09-17 | 2017-03-29 | 深圳翰宇药业股份有限公司 | A kind of preparation method of sitagliptin and its intermediate |
RS60393B1 (en) | 2014-02-03 | 2020-07-31 | Galenicum Health Sl | Stable pharmaceutical compositions containing sitagliptin in the form of immediate release tablets |
WO2015120111A2 (en) * | 2014-02-05 | 2015-08-13 | Stereokem, Inc. (Usa) | Expedient synthesis of sitagliptin |
WO2015162506A1 (en) | 2014-04-21 | 2015-10-29 | Suven Life Sciences Limited | Process for the preparation of sitagliptin and novel intermediates |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004085661A2 (en) * | 2003-03-24 | 2004-10-07 | Merck & Co., Inc | Process to chiral beta-amino acid derivatives |
WO2009085990A2 (en) * | 2007-12-20 | 2009-07-09 | Dr. Reddy's Laboratories Limited | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
-
2010
- 2010-08-27 WO PCT/US2010/046938 patent/WO2011025932A2/en active Application Filing
- 2010-08-27 EP EP10812650.9A patent/EP2470542A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004085661A2 (en) * | 2003-03-24 | 2004-10-07 | Merck & Co., Inc | Process to chiral beta-amino acid derivatives |
WO2009085990A2 (en) * | 2007-12-20 | 2009-07-09 | Dr. Reddy's Laboratories Limited | Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof |
Also Published As
Publication number | Publication date |
---|---|
WO2011025932A2 (en) | 2011-03-03 |
WO2011025932A3 (en) | 2011-07-21 |
EP2470542A2 (en) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2470542A4 (en) | Preparation of sitagliptin and salts thereof | |
IL215315A0 (en) | Solid state forms of sitagliptin salts | |
IL226489A0 (en) | Salts and crystalline forms of an apoptosis - inducing agent | |
HK1173654A1 (en) | Therapeutic compounds and related methods of use | |
ZA201107592B (en) | Salt of abt-263 and solid-state forms thereof | |
EP2548859A4 (en) | Preparation methods of methyl-d3-amine and salts thereof | |
EP2477628A4 (en) | Preparation of crystalline forms of dihydropyrazolopyrimidinone | |
EP2358658A4 (en) | Preparation of rasagiline and salts thereof | |
EP2464227A4 (en) | Compounds and methods of use thereof | |
EP2516404A4 (en) | Preparation of bendamustine and its salts | |
EP2647624A4 (en) | Intermediates of sitagliptin and preparation process thereof | |
EP2603176A4 (en) | C1-c2 implant and methods of use | |
HK1169379A1 (en) | Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof 3- | |
EP2702034A4 (en) | Preparation of fingolimod and its salts | |
ZA201209666B (en) | Salts and polymorhs of dexrabeprazole | |
EP2265586A4 (en) | Preparation of montelukast and its salts | |
EP2581369A4 (en) | Preparation process of dronedarone and its salts | |
EP2563768A4 (en) | Preparation of febuxostat | |
PL2501380T3 (en) | Slow infusion of sulcardine and its salts | |
EP2601200A4 (en) | Preparation of prasugrel hydrochloride | |
IL222714A0 (en) | Preparation of polypeptides and salts thereof | |
ZA201207945B (en) | Salts of dexlansoprazole and their preparation | |
PL2513099T3 (en) | Preparation of n-monofluoroalkyl tropanes | |
PT2655363T (en) | Crystalline forms and processes for their preparation | |
IL216782A0 (en) | Solid states forms of varenicline salts and processes for preparation therrof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120315 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130325 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 487/04 20060101AFI20130319BHEP Ipc: A61P 3/10 20060101ALI20130319BHEP Ipc: A61K 31/4985 20060101ALI20130319BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20131022 |